Sun Pharmaceutical Industries Ltd.
NSE: SUNPHARMA · Healthcare
Sector
Healthcare
Size band
Large cap
Market cap
4,12,326cr
P/E
102.5
ROE
17.8%
Dividend yield
0.9%
No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.
Measured against
Peer set
Pharmaceuticals & Drugs · largest 12 of 82 measured at Q1 FY27 · financials via Screener| Company | Operating margin | Revenue growth |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 29.0% | 10.5% |
| Divi's Laboratories Ltd. | 41.0% | 27.8% |
| Torrent Pharmaceuticals Ltd. | 34.0% | 54.8% |
| Lupin Ltd. | 30.0% | 32.1% |
| Dr. Reddy's Laboratories Ltd. | 11.0% | −5.5% |
| Cipla Ltd. | 17.0% | 2.3% |
| Zydus Lifesciences Ltd. | 24.0% | 22.0% |
| Mankind Pharma Ltd. | 26.0% | 12.9% |
| Aurobindo Pharma Ltd. | 21.0% | 16.3% |
| Torrent Power Ltd. | 19.0% | 2.8% |
| Alkem Laboratories Ltd. | 20.0% | 10.9% |
| Glenmark Pharmaceuticals Ltd. | 20.0% | 23.1% |
No guidance on record.
This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Sun Pharmaceutical Industries Ltd..
On air
20 calls · outcomes not trackedRecorded as stated on air, with the analyst's SEBI registration status where it was given. Anchor calls carry no registration and are marked. Bharatstox does not make, endorse or repeat these calls, and none of them is our view.
| Channel & show | Aired | Stated target | Stated stop | Outcome |
|---|---|---|---|---|
| Zee BusinessZee Business · no registration attached | 8 Oct | +15.1% | — | still open |
| Zee BusinessZee Business · no registration attached | 8 Oct | +25.5% | — | still open |
| Zee BusinessZee Business · no registration attached | 7 Oct | +16.4% | — | still open |
| Zee BusinessZee Business · no registration attached | 29 Sep | +1.4% | -1.4% | still open |
| Zee BusinessZee Business · no registration attached | 29 Sep | +1.1% | -1.6% | still open |
| Zee BusinessZee Business · no registration attached | 29 Sep | +1.2% | -1.5% | still open |
| Zee BusinessZee Business · no registration attached | 29 Sep | +2.3% | -1.2% | still open |
| Zee BusinessZee Business · no registration attached | 29 Sep | +2.4% | -1.1% | still open |
| Zee BusinessZee Business · no registration attached | 29 Sep | +1.6% | -1.1% | still open |
| Zee BusinessZee Business · no registration attached | 29 Sep | +16.3% | — | still open |
| NDTV ProfitNDTV Profit · no registration attached | 29 Sep | +22.4% | — | still open |
| NDTV ProfitNDTV Profit · no registration attached | 29 Sep | +17.0% | — | still open |
| Zee BusinessZee Business · no registration attached | 29 Sep | +2.0% | -2.3% | still open |
| Zee BusinessZee Business · no registration attached | 29 Sep | +17.4% | — | still open |
| Zee BusinessZee Business · no registration attached | 29 Sep | +17.0% | — | still open |
| Zee BusinessZee Business · no registration attached | 24 Sep | +6.9% | -0.4% | still open |
| Zee BusinessZee Business · no registration attached | 24 Sep | +2.6% | -0.4% | still open |
| Zee BusinessZee Business · no registration attached | 24 Sep | +2.6% | -0.3% | still open |
| Zee BusinessZee Business · no registration attached | 24 Sep | +2.7% | -0.3% | still open |
| Zee BusinessZee Business · no registration attached | 24 Sep | +1.4% | -1.5% | still open |
Shareholding
change across 4 filings| Category | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Change |
|---|---|---|---|---|---|
| Promoters | 52.7 | 54.5 | 54.5 | 54.5 | −1.8 |
| Foreign institutions | 14.4 | 14.5 | 15.9 | 16.1 | −1.7 |
| Domestic institutions | 22.3 | 22.2 | 21.1 | 20.8 | +1.5 |
| Retail & others | 10.7 | 8.8 | 8.5 | 8.6 | +2.1 |
As filed with the exchange for the periods ending Dec 25 to Sep 26.
Filings
latest 25 of 400- Analysts/Institutional Investor Meet/Con. Call Updates15 Oct 2026
- Certificate under SEBI (Depositories and Participants) Regulations, 201814 Oct 2026
- Credit Rating13 Oct 2026
- Resignation of Director/KMP/SMP12 Oct 2026
- Resignation12 Oct 2026
- Outcome of Board Meeting12 Oct 2026
- Press Release6 Oct 2026
- Copy of Newspaper Publication2 Oct 2026
- Shareholders meeting1 Oct 2026
- Press Release1 Oct 2026
- Copy of Newspaper Publication30 Sept 2026
- Updates29 Sept 2026
- Updates28 Sept 2026
- Press Release28 Sept 2026
- Trading Window25 Sept 2026
- Investor Presentation Sept-202622 Sept 2026
- Investor Presentation22 Sept 2026
- General Updates11 Sept 2026
- As attached11 Sept 2026
- General Updates9 Sept 2026
- Incorporation of wholly owned subsidiary of the Company in the International Financial Services Centre at GIFT City, Gandhinagar, Gujarat, India9 Sept 2026
- Credit Rating- New8 Sept 2026
- International Credit Ratings8 Sept 2026
- Intimation of Schedule of Analyst/Institutional Investor Meeting3 Sept 2026
- Analysts/Institutional Investor Meet/Con. Call Updates3 Sept 2026
The 25 most recent of 400 filings we hold for SUNPHARMA, back to January 2024. Every filing, by day.
Disclaimer
Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Broadcast calls are reproduced as stated on air, attributed, with the analyst's SEBI registration status where given; they are not our calls and not our view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.